Company / R&D per Share
Vivos Therapeutics, Inc. R&D per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.02
FY2025
5-year range
$0.01 / $0.22
FY2022-FY2025
Trend
-68.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.22 to $0.02 over the past 2 years.
Based on SEC 10-K filings.
0.02 in FY2025 with a 3-year CAGR of +25.0%.
Declined from $0.22 to $0.02 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +25.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 68.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -68.9% |
| FY2024 | $0.05 | -74.9% |
| FY2023 | $0.22 | +2399.7% |
| FY2022 | $0.01 | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026